Trade Groups Dismiss Jarrow’s Criticism Of FDA’s Fabricant
This article was originally published in The Tan Sheet
Dietary supplement industry trade groups disavow statements by Jarrow Formulas’ president that cast as industry consensus his criticism of Daniel Fabricant’s work as FDA’s top supplement program official.
You may also be interested in...
NPA credits its improved health and expanded member services to CEO Daniel Fabricant, who returned to the organization in April 2014 after three years at FDA. However, the exec is not without critics in the industry, and NPA now is embroiled in lawsuits defending the integrity of its leadership and fighting to remove a subversive element from its board of directors for alleged illegal conduct.
In lawsuits pending in DC District Court, former NPA CFO Brent Weickert claims he was wrongfully terminated after raising concerns with the trade group's board about CEO Daniel Fabricant's conduct, while NPA is suing to remove board members who allegedly conspired with Weickert to oust Fabricant and serve their own personal interests.
CEO Daniel Fabricant and the NPA board's president say former CFO Brent Weickert's allegations in a complaint filed in California state court are baseless. Weickert, with NPA from 1997 until October, says he was dismissed after he stated his concerns to NPA's board and to Fabricant.